Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NADX
Seems to be finally catching some attention after a strong earnings rebound. Volume is 10x average and the stock is moving higher. I think this one has an excellent chance for a return to the low 20's.
http://biz.yahoo.com/bw/070502/20070502005701.html?.v=1
KIK re:CHND
I haven't looked into this stock, but the Boca Raton, Florida headquarters is enough to raise a red flag for me.
ABMC will release earnings on Thursday May 10, 2007.
worthylion re:CSCT
I was aware of the registration filings. Those shares are well in the money, and they may be taking profits.
CSCT
I have no idea what happened to this stock today. But it opened down significantly at 12.18 and it has slowly rallied back to the mid 14s. I held my breath and added some share in the 13's. Time will tell if that was a good idea.
gilead23 re:ABMC
I had a little time today, so I decided to check out the CC. The growth prospects do sound promising. Combining the growth prospects, 49% gross margins and a focus on controlling operating costs. This one may be poised for a break out year.
I decided to initiate a position as well.
timhyma re:vifl
Keep in mind the ttm earnings is primarily the result of a large tax benefit in the last quarter.
researcher59 re:VII
I nibbled on a few shares on the pull back today.
TWOC
I don't own, but I thought I would let everyone know they earned .05 for the quarter. Results were lower if you adjust for currency.
hweb2 re:WWMU
I've been in this stock for a while now. I've been surprised it has taken this long for the second post on this stock.
http://www.investorshub.com/boards/read_msg.asp?Message_id=14887437&txt2find=wwmu
NADX
Reported a strong guarter .40 eps versus anal est. of .29. 5.5M shares outstanding. The stock is well off it 52 week high of 24.25 due to a couple of weak quarters. The bounce back this quarter may set it up for a return to the 20's.
manjb re:TCCO
I have no idea what the royalty formula is, but absent the technology transfer revenue which is a one time event. It looks like they would have incurred a loss for the quarter.
TCCO
I could be wrong but it looks like income was derived from non-recurring technology transfer revenue.
TO-low float earning alert
Company reported .18 eps. 2m shares in the float. They pay a dividend of .03 per quarter. The stock is up quite a bit, but the way these low floaters have been running it could go higher.
lentinman re: China stocks
If I understand what you were testing, it appears you may want to recheck HRBN. I show it first being mentioned on 6/08/2005. It was trading at 3.15. I'm still holding shares from 2005 that I purchased at that price.
I also believe CSCT was mentioned on these boards when it was in the $4-$5 range. I show the first post on 7/27/06 as part of your china index, but I know that I owned it well before that. I'm surprised their aren't any posts earlier than 7/27/06. CSCT used to trade under CSSTF.
KIK re:CNRD
With % of completion contract manufacturers, I've learned to rely on historical completed contract results rather than trusting the % of completion estimates. In 2004 new construction gross loss was 1.3M, 2005 gross profit was 165K and in 2006 gross loss was 758k. Their new construction track record leaves something to be desired.
With 54M+ in unhedged contracts and increasing steel costs, I wouldn't be surprised to see them continue to struggle with gross margins on new construction.
The repair side is obviously doing much better. The wild card for me is the scope and scale of the hurricane repair work.
bigpike re:CNRD
Hopefully that will prove to be true. They do report earnings based on % completion, so the financial statements to a degree are only as good as their estimates. Beware of the adjustments to estimates as the contracts near completion.
Steel prices have been moving up since the end of the year, so the margins on a large portion of their new construction are going to be under some pressure. I have to question a management that enters into long term construction contracts dependent on the price of raw materials and yet they refuse to hedge those input costs.
Hopefully they will hit the ball out of the park.
CNRD notes:
I don't own the stock, but I have been reviewing the annual report. A couple of notes from that review. Based on my understanding the backlog is for new construction projects. Historically, the company has not been profitable on new construction.
In 2006 the Company lost $758k on new construction. Compared to a gross profit of 165k in 2005. 27.1M of the backlog has steel price escalation clauses whereas the remaining 54.6M doesn't. I would use caution regarding reading too much into the increase in new construction backlog and future profit. If they continue to produce a negative gross profit similar to 2006 then this increase will actually turn out to have a negative impact on 2007 earnings.
The company made their money on repair services. This was driven primarily by hurricane repair and increased oil and gas related work. The oil and gas work is likely to continue with the higher gas prices, but it is hard to predict how long the hurricane repair work will continue. Good luck to all the longs.
Nelson re: CPHI
That filing was for the purpose of registering the shares involved in the the previously announced public offering. It is not an additional offering.
larrybaz-re:ffhl
They have considerably more shares outstanding then the recent earnings reflect. They earned .66 for 2006 based on the 13M shares outstanding at the end of the year.
msgi
There is a difference between cphi and chme. CHME is primarily a traditional chinese pharma company. Traditional Chinese medicines are primarily natural herbs.
CHPI on the other hand is a generic and branded drug manufacturer. They take drugs coming off patents and manufacturer generics.
Re: CHME
I agree with KIK and Researcher. I've looked into this one in the past and I would be very careful regarding dilution, Barron Partners, and the crack down in China related to this type of Company.
larrybaz
try stockhouse.com
JST
I may be tempted to do some table pounding on this one.
They have over $4 per share in cash. They earned $.39 for the 4th quarter and $1.11 for the calanedar year 2006.
Today they issued a follow up press release forecasting 40-45% sales growth and 55-60% eps growth for 2007.
BSHI
With .59 in tax adjusted earnings, flat sales and declining margins this one looks more like a balance sheet play than an earnings play.
BSHI
Per 10k
Due to the recent trend of improved earnings in the Company’s traditional operating segments and current projected earnings, management concluded during the fourth quarter of 2006, that the Company should recognize an additional portion of the tax benefit associated with its net operating loss (“NOL”) carryforwards. Accordingly, the Company recorded a non-cash tax benefit of $2,730,000. With improved operating income and the recognition of a significant tax benefit, the Company recorded net earnings of $3,894,000 for 2006. Excluding the tax benefit of $2,730,000, net income after tax would total approximately $1,164,000 or basic net earnings per share of $0.59
Overall, management anticipates modest sales growth in the coming year with operating expenses remaining relatively stable. Margins are likely to remain under pressure in 2007, with cost increases continuing for a number of products. By focusing on improved customer profitability, supply chain efficiency, inventory utilization and sales growth in higher margin areas, management intends to offset cost increases.
JST reports .39 esp for the the fourth quarter
Revenues for the 4th q were 24.4 and eps .39 up sequentially from 23.3 and .32 reported in the 3rd quarter. JST is my largest china holding. Solid balance sheet and pays a dividend. They have also demonstrated consistent growth.
abh3vt re: cphi
Good point on factoring in the recent dilution. Still impressive earnings relative to the current price if they can execute as planned.
MFIC
I would probably consider buying if there wasn't such a large sequential drop in the backlog. The year end backlog is up roughly 11% from the prior year, but down roughly 37% from the end of the 3rd quarter.
wade re: cphi
That would only be speculation on my part. The company is forecasting in excess of .32 in eps for 2007. If they execute on that, then I would expect it will trend up over time.
wade re: cphi.ob
The Dec 05 quarter contained a one time gain from the sale of technology property.
2morrowsGains re: TSTC
That was a great quarter. Much better than I was expecting. They've been announcing a lot of contract wins in the last few months, so things look good for 2007. It will be interesting to see if, the stock can challenge the 52 week high.
tssw.ob
It will be interesting to see how the recent launch of Vista impacts the company's earnings in 2007.
MikeS97707 re: SMTX
I'm curious what they meant by growing earnings at a greater rate then revenues. More specifically, I wonder if he meant operating earnings versus net income?
If so, it should be noted that one caller asked about interest expense, and per management it is expected to run at about $2M per quarter which would be $8m annually compared to $5.4M in 2006. At $2m per quarter, interest expense will have a .17 negative impact on 2007 earnings compared to 2006.
worthylion re: CSCT
If you haven't listened to the conference call, I would recommend that you take the time to do so. There's some good information about the future prospects for CSCT.
The current quarter came in .02 above the concensus estimates of .2.
hweb2 re:CIMT
I flipped my shares as well at $3.
hweb2 re: CIMT
The company has $5.6M in cash and short term investments plus $2M in long term investments which is comprised of corporate bonds of roughly 1.25M and .75M in an investment in an affiliate.
They have a history of reporting other income as well. Based on what I've seen, I have seen no indication of a tax benefit.
abh3vt- the reclassification should occur as of the date of the event which leads to reclassification.
Therefore, I believe it will be necessary to mark the contract to market up to that date. Thus, there should be one final adjustment to the fair value in the first quarter.
abh3vt re: HRBN
The classification of the warrants should be reassessed at each balance sheet date. If the contract is reclassified from a liability to equity, gains or losses recorded to account for the contract at fair value during the period the contract was classified as an asset or liability should not be reversed.
Assuming the derivatives will now meet the requirements for being delivered in shares and not cash, the liability should be transferred to equity in the first quarter. Subsequent changes in the value of the warrants will no longer be recognized in the financial statements.
The debt discount should remain unchanged and should continue to be amortized over the life of the loan.
2morrowsGains-re: HRBN
I still contend that this quarter was much stronger than it appears on the surface. The accounting for the 50M in debt financing has really complicated earnings.
Because of the warrants attached to the debt, they had to allocate significant value to the warrants which led to a huge discount on the debt which is going to be amortized over the loan period. This discount is a non-cash event which distorts the actual interest that is being paid on the notes. To understand the true interest being paid, it is necessary to back out the discount amortization.
I was not disappointed by this quarter because I knew these distortions were coming. I was very happy to see the sequential growth in revenues and the strong operating earnings.